Digital Therapeutics Market to 2025- Global Analysis and Forecasts by Application (Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, Others); Distribution Channel (Patients, Providers, Payers, and Employers) and Geography
The digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant rate in Asia Pacific (APAC) region during the forecast period. Factors such as, increasing prevalence of the chronic diseases, acceptance of the digital health platforms, developments performed by the market players in the countries such as India, China, Australia and others are likely to propel growth of the market.
Lucrative Regional Markets Get more information on this report : 
Market Insights
Rising prevalence of chronic diseases to boost market growth
Chronic diseases, including heart disease, stroke, diabetes, and obesity, are the leading causes of death in the world and account for most of the nation’s health care costs. According to report of CDC, in 2018, approximately more than 9% of the population has diabetes, which is the leading cause of kidney failure, lower-limb amputations in US. Moreover, the data also suggests that 1.5 million Americans are diagnosed with diabetes every year in the US. Similar trends for high presence of diabetes are prevalent around other geographies of the globe that include Asia Pacific, Europe, Middle East and Africa. For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation in 2017, south-east Asia is home to approximately one-fifth (19%) of the total diabetes population worldwide. According to the report of American College of Cardiology Foundation, in 2018, Coronary heart disease (CHD) was the leading cause of deaths attributable to cardiovascular disease (CVD) in the US, which is followed by stroke (16.8%), high BP (9.4%), heart failure (HF) (9.0%), and other CVDs (17.9%). By 2035, approximately 130 million adults in the US population are projected to have some form of CVD. Thus, increasing geriatric population and related chronic diseases are expected to propel the growth of global digital therapeutics market over the forecast years.
Rising Pressure on Healthcare Providers to Reduce Healthcare Costs
Digital therapeutics help in reducing the costs associated with chronic diseases, by helping an individual or an insurance provider to keep a track of one’s health status as well as track it with the help of digital means. As per American Diabetes Association, the estimated costs of diagnosed diabetes have risen to $327 billion in 2017, including $237 billion in direct medical costs and $90 billion in reduced productivity. This cost can be managed efficiently by including digital therapeutics that are offered by providers to help manage diabetes, can help patients get assistance with disease management and overcome the logistical challenges uncovered by the investigators.
Application Insights
The digital therapeutics market by application is segmented into diabetes, cardiovascular diseases, and central nervous system diseases, respiratory diseases, smoking cessation, musculoskeletal diseases and others. In 2017, the diabetes segment held a largest market share of 26.6% of the digital therapeutics, by application. This segment is also expected to dominate the market in 2025. The growth of the market is primarily attributed to the rising prevalence of diabetes cases across the globe and also the segment is expected to grow with the fastest growth rate of 22.0% during the forecast period, 2018 to 2025.
Distribution Channel Insights
On the basis of distribution channel, the digital therapeutics market is segmented into patients, providers, payers, and employers. In 2017, the patients segment is expected to dominate the market based on the distribution channel contributing a share of 39.2%. This is primarily attributed to growing prevalence for the need to self-monitor as well as manage one’s health status. However, providers segment is anticipated to grow at a fastest growth rate of 21.3% during the forecast period.
Strategic Insights
Product launch/update and partnerships were observed as the most adopted strategy in global digital therapeutics industry. Few of the product approvals and partnerships made by the players in the market are listed below:
2017: In November, Propeller Health and Express Scripts entered into a partnership to provide Propeller’s FDA-cleared digital solutions to Express Scripts to manage asthma or COPD.
2016: In November, Propeller Health received FDA approval for its Propeller platform for use with GSK’s Ellipta inhaler.
2018: In April, Canary Health entered into a partnership with NMRHCA to offer the Better Choices, Better Health (BCBH) digital therapeutics program in New Mexico.
2016: In June, Canary Health partnered with Medtronic to expand their diabetes care offerings with Canary Health's self-management suite for pre-diabetes, diabetes and related comorbidities.
DIGITAL THERAPEUTICS – MARKET SEGMENTATION
By Application
- Diabetes
- Cardiovascular Diseases
- Central Nervous System (CNS) Disease
- Respiratory Diseases
- Smoking Cessation
- Musculoskeletal Diseases
- Other Applications
By Distribution Channel
- Patients
- Providers
- Payers
- Employers
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Asia Pacific (APAC)
- China
- India
- Japan
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- UAE
- South America (SAM)
- Brazil
Company Profiles
- Propeller Health
- CANARY HEALTH
- Noom, Inc.
- 2Morrow Inc.
- Livongo Health
- Proteus Digital Health
- WellDoc, Inc.
- Fitbit, Inc.
- Omada Health, Inc.
- MANGO HEALTH
TABLE OF CONTENTS
1. INTRODUCTION 18
1.1 SCOPE OF THE STUDY 18
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 18
2. GLOBAL DIGITAL THERAPEUTICS MARKET - KEY TAKEAWAYS 19
3. GLOBAL DIGITAL THERAPEUTICS MARKET - MARKET LANDSCAPE 21
3.1 OVERVIEW 21
3.2 MARKET SEGMENTATION 21
3.2.1 Global Digital Therapeutics Market- By Application 22
3.2.2 Global Digital Therapeutics Market - By Distribution Channel 22
3.2.3 Global Digital Therapeutics Market - By Geography 23
3.3 PEST ANALYSIS 24
3.3.1 North America - PEST Analysis 24
3.3.2 Europe - PEST Analysis 26
3.3.3 Asia Pacific - PEST Analysis 28
3.3.4 Middle East and Africa (MEA) - PEST Analysis 30
3.3.5 South and Central America - PEST Analysis 32
4. GLOBAL DIGITAL THERAPEUTICS MARKET - KEY MARKET DYNAMICS 34
4.1 KEY MARKET DRIVERS 34
4.1.1 Rising Prevalence of Chronic Diseases 34
4.1.2 Rising Pressure on Healthcare Providers to Reduce Healthcare Costs 35
4.1.3 Rising in the Number of Partnerships and Collaborations in the Market 35
4.2 KEY MARKET RESTRAINTS 36
4.2.1 Cyber Threat and Rise in Data Security 36
4.3 KEY MARKET OPPORTUNITY 36
4.3.1 Large Number of Undiagnosed Population 36
4.4 FUTURE TREND 38
4.4.1 Increase in the Number of Start Ups 38
4.5 IMPACT ANALYSIS 39
5. DIGITAL THERAPEUTICS MARKET- GLOBAL ANALYSIS 40
5.1 GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN) 40
5.2 GLOBAL DIGITAL THERAPEUTICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 41
5.3 PROMINENT PLAYERS 42
5.4 PERFORMANCE OF KEY PLAYERS 42
5.4.1 Propeller Health 42
5.4.2 CANARY HEALTH 42
5.5 EXPERT OPINIONS 43
6. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS - BY APPLICATION 44
6.1 OVERVIEW 44
6.2 DIABETES MARKET 45
6.2.1 Overview 45
6.2.2 Global Diabetes Market Revenue and Forecasts to 2025 (US$ Mn) 45
6.3 CARDIOVASCULAR DISEASE MARKET 46
6.3.1 Overview 46
6.3.2 Global Cardiovascular Disease Market Revenue and Forecasts to 2025 (US$ Mn) 46
6.4 CENTRAL NERVOUS SYSTEM DISEASE MARKET 47
6.4.1 Overview 47
6.4.2 Global Central Nervous System Disease Market Revenue and Forecasts to 2025 (US$ Mn) 47
6.5 RESPIRATORY DISEASES MARKET 48
6.5.1 Overview 48
6.5.2 Global Respiratory Disease Market Revenue and Forecasts to 2025 (US$ Mn) 48
6.6 SMOKING CESSATION MARKET 49
6.6.1 Overview 49
6.6.2 Global Smoking Cessation Market Revenue and Forecasts to 2025 (US$ Mn) 49
6.7 MUSCULOSKELETAL DISEASE MARKET 50
6.7.1 Overview 50
6.7.2 Global Musculoskeletal Disease Market Revenue and Forecasts to 2025 (US$ Mn) 50
6.8 OTHER APPLICATIONS MARKET 51
6.8.1 Overview 51
6.8.2 Global Other Applications Market Revenue and Forecasts to 2025 (US$ Mn) 51
7. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS - BY DISTRIBUTION CHANNEL 52
7.1 OVERVIEW 52
7.2 PATIENTS MARKET 53
7.2.1 Overview 53
7.2.2 Global Patients Market Revenue and Forecasts to 2025 (US$ Mn) 53
7.3 PROVIDERS MARKET 54
7.3.1 Overview 54
7.3.2 Global Providers Market Revenue and Forecasts to 2025 (US$ Mn) 54
7.4 PAYERS MARKET 55
7.4.1 Overview 55
7.4.2 Global Payers Market Revenue and Forecasts to 2025 (US$ Mn) 55
7.5 EMPLOYERS MARKET 56
7.5.1 Overview 56
7.5.2 Global Employers Market Revenue and Forecasts to 2025 (US$ Mn) 56
8. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 57
8.1 OVERVIEW 57
8.2 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
8.3 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN) 58
8.4 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY DISTRIBUTION CHANNEL (US$ MN) 59
8.5 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017-2025) (%) 59
8.6 US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
8.6.1 US Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 61
8.6.2 US Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 61
8.6.3 US Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 62
8.7 CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
8.7.1 Canada Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 64
8.7.2 Canada Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 64
8.7.3 Canada Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 65
8.8 MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
8.8.1 Mexico Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 67
8.8.2 Mexico Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 67
8.8.3 Mexico Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 68
9. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 69
9.1 OVERVIEW 69
9.2 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.3 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 70
9.4 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 71
9.5 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 71
9.6 GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
9.6.1 Germany Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 73
9.6.2 Germany Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 73
9.6.3 Germany Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 74
9.7 UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
9.7.1 UK Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 76
9.7.2 UK Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 76
9.7.3 UK Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 77
9.8 FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
9.8.1 France Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 78
9.8.2 France Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 79
9.8.3 France Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 79
10. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 80
10.1 OVERVIEW 80
10.2 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
10.3 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81
10.4 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 82
10.5 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 82
10.6 JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
10.6.1 Japan Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 83
10.6.2 Japan Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84
10.6.3 Japan Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 84
10.7 CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
10.7.1 China Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 86
10.7.2 China Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 86
10.7.3 China Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 87
10.8 INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
10.8.1 India Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 89
10.8.2 India Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 89
10.8.3 India Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 90
11. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 91
11.1 OVERVIEW 91
11.2 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 92
11.3 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
11.4 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 93
11.5 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 93
11.6 UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 94
11.6.1 UAE Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 94
11.6.2 UAE Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 95
11.6.3 UAE Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 95
11.7 SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 96
11.7.1 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 96
11.7.2 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 97
11.7.3 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 97
11.8 SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 98
11.8.1 South Africa Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 98
11.8.2 South Africa Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 99
11.8.3 South Africa Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 99
12. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 100
12.1 OVERVIEW 100
12.2 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
12.3 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 101
12.4 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 102
12.5 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 102
12.6 BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
12.6.1 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 104
12.6.2 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 104
12.6.3 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 105
12.6.4 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Pharmaceutical Service (US$ Mn) 105
13. DIGITAL THERAPEUTICS MARKET-KEY COMPANY PROFILES 106
13.1 PROPELLER HEALTH 106
13.1.1 Key Facts 106
13.1.2 Business Description 106
13.1.3 Financial Overview 107
13.1.4 Product/Services Portfolio 107
13.1.5 SWOT Analysis 107
13.1.6 Key Developments 107
13.2 CANARY HEALTH 109
13.2.1 Key Facts 109
13.2.2 Business Description 109
13.2.3 Financial Overview 109
13.2.4 Product/Service Portfolio 109
13.2.5 SWOT Analysis 110
13.2.6 Key Developments 110
13.3 NOOM, INC. 111
13.3.1 Key Facts 111
13.3.2 Business Description 111
13.3.3 Financial Overview 111
13.3.4 Product/Services Portfolio 111
13.3.5 SWOT Analysis 112
13.3.6 Key Developments 112
13.4 2MORROW INC. 113
13.4.1 Key Facts 113
13.4.2 Business Description 113
13.4.3 Financial Information 113
13.4.4 Product/Services Portfolio 113
13.4.5 SWOT Analysis 114
13.4.6 Key Developments 114
13.5 LIVONGO HEALTH 115
13.5.1 Key Facts 115
13.5.2 Business Description 115
13.5.3 Financial Information 115
13.5.4 Product/Service Portfolio 115
13.5.5 SWOT Analysis 116
13.5.6 Key Developments 116
13.6 PROTEUS DIGITAL HEALTH 118
13.6.1 Key Facts 118
13.6.2 Business Description 118
13.6.3 Financial Information 118
13.6.4 Product/Service Portfolio 118
13.6.5 SWOT Analysis 119
13.6.6 Key Developments 119
13.7 WELLDOC, INC 120
13.7.1 Key Facts 120
13.7.2 Business Description 120
13.7.3 Financial Overview 120
13.7.4 Product/Service Portfolio 120
13.7.5 SWOT Analysis 121
13.7.6 Key Developments 121
13.8 FITBIT, INC. 123
13.8.1 Key Facts 123
13.8.2 Business Description 123
13.8.3 Financial Overview 124
13.8.4 Product/Service Portfolio 124
13.8.5 SWOT Analysis 125
13.8.6 Key Developments 125
13.9 OMADA HEALTH, INC. 128
13.9.1 Key Facts 128
13.9.2 Business Description 128
13.9.3 Financial Overview 128
13.9.4 Product/Service Portfolio 128
13.9.5 SWOT Analysis 129
13.9.6 Key Developments 129
13.10 MANGO HEALTH 130
13.10.1 Key Facts 130
13.10.2 Business Description 130
13.10.3 Financial Overview 130
13.10.4 Product/Service Portfolio 130
13.10.5 SWOT Analysis 131
13.10.6 Key Developments 131
14. APPENDIX 132
14.1 ABOUT THE INSIGHT PARTNERS 132
14.2 GLOSSARY OF TERMS 132
14.3 METHODOLOGY 134
14.4 COVERAGE 135
14.5 SECONDARY RESEARCH 136
14.6 PRIMARY RESEARCH 136
LIST OF TABLES
TABLE 1. PROPORTION OF PEOPLE LIVING WITH DIABETES (20-79 YEARS) WHO ARE UNDIAGNOSED PER REGION, 2017 37
TABLE 2. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 58
TABLE 3. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 61
TABLE 4. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 62
TABLE 5. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 64
TABLE 6. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 65
TABLE 7. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 67
TABLE 8. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 68
TABLE 9. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 70
TABLE 10. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 71
TABLE 11. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 73
TABLE 12. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 74
TABLE 13. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76
TABLE 14. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 77
TABLE 15. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
TABLE 16. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 79
TABLE 17. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81
TABLE 18. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 82
TABLE 19. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
TABLE 20. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 84
TABLE 21. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 86
TABLE 22. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 87
TABLE 23. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 89
TABLE 24. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 90
TABLE 25. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
TABLE 26. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 93
TABLE 27. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 95
TABLE 28. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 95
TABLE 29. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
TABLE 30. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 97
TABLE 31. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 99
TABLE 32. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 99
TABLE 33. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 101
TABLE 34. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 102
TABLE 35. BRAZIL DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104
TABLE 36. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 105
TABLE 37. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY PHARMACEUTICAL SERVICE (US$ MN) 105
TABLE 38. GLOSSARY OF TERMS, DIGITAL THERAPEUTICS MARKET 132
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 19
FIGURE 2. GLOBAL DIGITAL THERAPEUTICS MARKET BY APPLICATION, MARKET SHARE (%), 2017 20
FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, MARKET SHARE (%), 2017 20
FIGURE 4. DIGITAL THERAPEUTICS MARKET SEGMENTATION 21
FIGURE 5. DIGITAL THERAPEUTICS MARKET SEGMENTATION, BY REGION 22
FIGURE 6. NORTH AMERICA PEST ANALYSIS 24
FIGURE 7. EUROPE PEST ANALYSIS 26
FIGURE 8. ASIA PACIFIC PEST ANALYSIS 28
FIGURE 9. MIDDLE EAST AND AFRICA (MEA) PEST ANALYSIS 30
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 32
FIGURE 11. DIGITAL THERAPEUTICS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 39
FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET- REVENUE FORECASTS AND ANALYSIS - 2017- 2025 (US$ MN) 40
FIGURE 13. GLOBAL DIGITAL THERAPEUTICS MARKET- BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 41
FIGURE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SHARES BY APPLICATION, 2017 & 2025 (%) 44
FIGURE 15. GLOBAL DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 16. GLOBAL CARDIOVASCULAR DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
FIGURE 17. GLOBAL CENTRAL NERVOUS SYSTEM DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 18. GLOBAL RESPIRATORY DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 19. GLOBAL SMOKING CESSATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
FIGURE 20. GLOBAL MUSCULOSKELETAL DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 21. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SHARES BY DISTRIBUTION CHANNEL, 2017 & 2025 (%) 52
FIGURE 23. GLOBAL PATIENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
FIGURE 24. GLOBAL PROVIDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 25. GLOBAL PAYERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 26. GLOBAL EMPLOYERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 27. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 57
FIGURE 28. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
FIGURE 29. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017-2025) (%) 59
FIGURE 30. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 31. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
FIGURE 32. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
FIGURE 33. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (%) 69
FIGURE 34. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
FIGURE 35. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 71
FIGURE 36. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 37. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
FIGURE 38. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
FIGURE 39. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017), (US$ MN) 80
FIGURE 40. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
FIGURE 41. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 82
FIGURE 42. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
FIGURE 43. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
FIGURE 44. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
FIGURE 45. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 91
FIGURE 46. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 92
FIGURE 47. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 93
FIGURE 48. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 94
FIGURE 49. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 50. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 98
FIGURE 51. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 100
FIGURE 52. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
FIGURE 53. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 102
FIGURE 54. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 104
The List of Companies - Digital Therapeutics Market
1. Propeller Health
2. CANARY HEALTH
3. Noom, Inc.
4. 2Morrow Inc.
5. Livongo Health
6. Proteus Digital Health
7. WellDoc, Inc.
8. Fitbit, Inc.
9. Omada Health, Inc.
10. MANGO HEALTH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the digital therapeutics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution